SIRT1 negatively regulates the mammalian target of rapamycin.
The IGF/mTOR pathway, which is modulated by nutrients, growth factors, energy status and cellular stress regulates aging in various organisms. SIRT1 is a NAD+ dependent deacetylase that is known to regulate caloric restriction mediated longevity in model organisms, and has also been linked to the in...
Main Authors: | Hiyaa Singhee Ghosh, Michael McBurney, Paul D Robbins |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-02-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20169165/pdf/?tool=EBI |
Similar Items
-
Mammalian target of rapamycin inhibitors: A paradigm shift in current immunosuppression protocols
by: Indranil Ghosh, et al.
Published: (2016-01-01) -
Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases
by: Michael Wong
Published: (2014-04-01) -
Regulation of mammalian target of rapamycin on ferroptosis: from mechanism to therapeutics in septic cardiomyopathy
by: Guoyu Zhao, et al.
Published: (2022-12-01) -
The role of mammalian target of rapamycin complex 1 in hepatic physiology and disease
by: Sengupta, Shomit
Published: (2010) -
Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
by: Junfang Yan, et al.
Published: (2021-01-01)